Camp4 Therapeutics Corp
CAMPAs of the close on Sep 25, 2026
Price
$3.92
Market cap
$246M
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Camp4 Therapeutics Corp Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 2026-03-31 | 653,594 | Not shown | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 9,505 | Not shown | SEC filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2026-03-31 | 1,960,784 | Not shown | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 108,875 | Not shown | SEC filing |
| Scientech Research LLC | 2026-03-31 | 12,735 | Not shown | SEC filing |
| JANUS HENDERSON GROUP PLC | 2026-03-31 | 6,307,636 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 1,405 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 146,900 | Not shown | SEC filing |
| CITIGROUP INC | 2026-03-31 | 9,887 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 70,666 | Not shown | SEC filing |
| China Universal Asset Management Co., Ltd. | 2026-03-31 | 16,000 | Not shown | SEC filing |
| Vivo Capital, LLC | 2026-03-31 | 4,246,568 | Not shown | SEC filing |
| FMR LLC | 2026-03-31 | 4,933,432 | Not shown | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 336,047 | Not shown | SEC filing |
| SummitTX Capital, L.P. | 2026-03-31 | 339,521 | Not shown | SEC filing |
| Trails Edge Capital Partners, LP | 2026-03-31 | 1,939,563 | Not shown | SEC filing |
| Point72 Asset Management, L.P. | 2026-03-31 | 17,326 | Not shown | SEC filing |
| Diametric Capital, LP | 2026-03-31 | 14,446 | Not shown | SEC filing |
| Stonepine Capital Management, LLC | 2026-03-31 | 1,389,622 | Not shown | SEC filing |
| Qube Research & Technologies Ltd | 2026-03-31 | 24,803 | Not shown | SEC filing |
- Each value is checked against Camp4 Therapeutics Corp's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- 5AM Venture Management, LLC: 5,869,091 shares reported 2025-12-31; 5,869,091 shares reported 2026-03-31.
- BARCLAYS PLC: 73,601 shares reported 2025-12-31; 34,693 shares reported 2026-03-31.
- 683 Capital Management, LLC: 126,363 shares reported 2025-12-31; 108,000 shares reported 2026-03-31.
- BANK OF AMERICA CORP /DE/: 22 shares reported 2025-12-31; 31,196 shares reported 2026-03-31.
- SBI Securities Co., Ltd.: 10 shares reported 2025-12-31; 10 shares reported 2026-03-31.
- BlackRock, Inc.: 390,160 shares reported 2025-12-31; 456,371 shares reported 2026-03-31.
- a16z Capital Management, L.L.C.: 2,125,339 shares reported 2025-12-31; 2,125,339 shares reported 2026-03-31.
- MILLENNIUM MANAGEMENT LLC: 10,102 shares reported 2025-12-31; 85,918 shares reported 2026-03-31.
- UBS Group AG: 5,145 shares reported 2025-12-31; 9,081 shares reported 2026-03-31.
- BNP PARIBAS FINANCIAL MARKETS: 33 shares reported 2025-12-31; 36 shares reported 2026-03-31.
- HarbourVest Partners LLC: 1,271,948 shares reported 2025-12-31; 1,271,948 shares reported 2026-03-31.
- BRIDGEWAY CAPITAL MANAGEMENT, LLC: 25,000 shares reported 2025-12-31; 25,000 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
16 filers have only one report here.
Independent insiders buying near the same time
- 2025-09-11–2025-09-11: 9 event(s) across 7 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-11 | Chee Brian · 10% owner | Common Stock | P — Open market or private purchase | +1,221,721 | 1.53 | SEC filing |
| 2025-09-11 | Nashat Amir · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,221,721 | 1.53 | SEC filing |
| 2025-09-11 | Chee Brian · 10% owner | Common Stock | P — Open market or private purchase | +85,468 | 1.53 | SEC filing |
| 2025-09-11 | Gold Kelly · Chief Financial Officer | Common Stock | P — Open market or private purchase | +6,060 | 1.65 | SEC filing |
| 2025-09-11 | Mandel-Brehm Josh · Chief Executive Officer | Common Stock | P — Open market or private purchase | +6,060 | 1.65 | SEC filing |
| 2025-09-11 | Nashat Amir · Director, 10% owner | Common Stock | P — Open market or private purchase | +85,468 | 1.53 | SEC filing |
| 2025-09-11 | PARMAR KUSH · 10% owner | Common Stock | P — Open market or private purchase | +2,941,176 | 1.53 | SEC filing |
| 2025-09-11 | Maricich Yuri · Chief Medical Officer | Common Stock | P — Open market or private purchase | +6,060 | 1.65 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-10 | WILLIAMS DOUGLAS E · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-10 | Holtzman Steven H · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-10 | Schwab Andrew J. · Director, 10% owner | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-10 | Nashat Amir · Director, 10% owner | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-10 | Young Richard A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-10 | Stewart Murray · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-04-01 | Gold Kelly · Chief Financial Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +215,000 | SEC filing |
| 2026-04-01 | MacLean Michael F · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +56,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.